tirzepatide surmount 5 For the first time, and semaglutide were put in the same trial. SURMOUNT-5. Phase 3b RCT. 751 adults with obesity, no diabetes. 72 weeks. Both drugs at maximum tolerated dose. The Tirzepatide vs Semaglutide: SURMOUNT-5 Results

After a few weeks without tirzepatide, tolerance falls, and resuming at full strength can overwhelm the system

Epithalon not only decelerates aging, it also suppresses development of breast adenocarcinomas in transgenic Her-2/neu mice

For many, this efficiency manifests as a drop in core body temperature or a heightened sensitivity to cool environments

Recalls & Warnings April 17, 2020 Arthritis Supplement Recalled for Salmonella Risk On April 13, 2020, Arthri-D, LLC issued a recall of one lot of Arthri-D arthritis supplement because recent testing found it has the potential to be contaminated with Salmonella

Presented for research literature review only Anand P et al